Thomas Chalopin
Impact in
-
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Yersinia bacterium, plague, ectoparasites research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 12
- Multiple Myeloma Research and Treatments 10
- Chronic Myeloid Leukemia Treatments 2
-
- Protein Degradation and Inhibitors 4
- Amyloidosis: Diagnosis, Treatment, Outcomes 4
- Co-authors
- Nicolas Vallet (5 shared papers)Emmanuel Gyan (5 shared papers)Olivier Hérault (5 shared papers)Louis Bernard (2 shared papers)Louis d’Altéroche (1 shared paper)Alban Villate (3 shared papers)Laurianne Drieu La Rochelle (2 shared papers)Philippe Colombat (1 shared paper)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (3 papers)BMC Infectious Diseases (2 papers)Annals of Hematology (2 papers)BMJ Supportive & Palliative Care (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Thomas Chalopin
16 papers receiving 53 citations
Peers
Comparison fields: 5 of 38
- Hematology 19
- Genetics 7
- Virology 3
- Oncology 15
- Emergency Medical Services 3
Countries citing papers authored by Thomas Chalopin
This map shows the geographic impact of Thomas Chalopin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Chalopin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Chalopin more than expected).
Fields of papers citing papers by Thomas Chalopin
This network shows the impact of papers produced by Thomas Chalopin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Chalopin. The network helps show where Thomas Chalopin may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Chalopin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 10 | |
| 2 | 2020 | 8 | |
| 3 | 2021 | 7 | |
| 4 | 2020 | 5 | |
| 5 | 2017 | 5 | |
| 6 | 2018 | 4 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2024 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2024 | 0 | |
| 20 | 2024 | 0 |
About Thomas Chalopin
Thomas Chalopin is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Infectious Diseases, having authored 20 papers that have together received 54 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Cancer Treatment and Pharmacology (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Hematology (19 citations), Genetics (7 citations), Virology (3 citations), Oncology (15 citations) and Emergency Medical Services (3 citations). Thomas Chalopin has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Nicolas Vallet, Emmanuel Gyan, Olivier Hérault, Louis Bernard, Louis d’Altéroche, Alban Villate, Laurianne Drieu La Rochelle, Philippe Colombat, Laurent Sutton and Gonzague de Pinieux. Their work appears in journals such as Blood, Journal of Clinical Oncology, BMC Infectious Diseases, Annals of Hematology and BMJ Supportive & Palliative Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.